Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (19187)	3/29/2004 11:46:03 AM
From: articleman	Respond to of 120405

CAMY - news: CAS Medical Systems, Inc. Announces a Further Extension of its OEM Agreement with Medtronic Physio-Control Monday March 29, 11:38 am ET BRANFORD, Conn., March 29 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. (OTC Bulletin Board: CAMY - News) today announced the further multi-year extension of its OEM Agreement to supply non-invasive blood pressure (NIBP) technology to Medtronic Physio-Control of Redmond, WA. Medtronic Physio- Control is the recognized world leader in the manufacture, sale and service of external defibrillators and related medical equipment. CAS has been providing its NIBP technology in the form of modules to Medtronic Physio-Control since 1999. The CAS NIBP technology is used in the Medtronic Physio-Control LIFEPAK® 12 defibrillator/monitor. The LIFEPAK 12 provides therapeutic and diagnostic functions in a single, small device designed for both out-of-hospital and hospital users. The innovative platform design provides full-featured defibrillation and industry-standard monitoring parameters, including CAS' NIBP. Under the multi-year agreement extension, CAS will continue to provide NIBP technology to Medtronic Physio-Control for its monitoring systems. Louis P. Scheps, President and CEO of CAS Medical Systems, Inc. states, "Our relationship with Medtronic Physio-Control is one of which we are very proud. We are committed to providing the highest level of quality and service to our OEM partners which, along with the superiority of our NIBP technology, has enabled us to extend the term of this supply agreement." CAS Medical Systems, Inc. supplies its MAXNIBP® non-invasive blood pressure technology to leading manufacturers of multi-parameter vital signs monitoring systems worldwide. The patented technology is among the most advanced NIBP measurement systems available, especially in clinical situations where measurements can be difficult. CAS also manufactures and sells a line of stand-alone vital signs monitors with MAXNIBP technology, along with options for pulse oximetry and temperature, for use in a range of clinical settings including emergency medical services, medical/surgical units and routine hospital patient care. Founded in 1984, CAS Medical Systems, Inc. designs, manufactures and markets medical products, specifically blood pressure measurement technology, vital signs monitoring equipment, apnea monitoring equipment and products for neonatal intensive care. The Company's products are designed to improve the quality of patient care and provide exceptional value and performance. With a reputation for the highest quality products available in the market it serves, CAS' products are used by clinicians worldwide.

To: GARY P GROBBEL who wrote (19187)	3/29/2004 12:03:35 PM
From: GARY P GROBBEL	Read Replies (2) \| Respond to of 120405

PFCE...patent issued..read carefully...there is dynamite somewhere in this company (GGG): (BSNS WIRE) Pacific Fuel Cell Corp. Announces United States Patent Pacific Fuel Cell Corp. Announces United States Patent Energy Editors / Business Editors TUSTIN, Calif.--(BUSINESS WIRE)--PFCE-- Pacific Fuel Cell Corp. (OTCBB:PFCE) is pleased to announce that United States Patent 6,706,431 has been issued and assigned to Fullerene USA, Inc., PFCE's parent company. The abstract reads as follows: "A fuel cell having an electrode and/or catalyst formed from a nano-carbon material, such as fullerene, carbon nanotube, carbon nanohorn, carbon nano-fiber or metal encapsulated fullerene. Such fuel cells may not use platinum in the electrode or catalyst, or may use platinum in small amounts. The efficiency of the fuel cell may be increased by applying external energy to the electrode and/or catalyst. A cationic membrane may be positioned between the cathode and anode of the fuel cell. Also disclosed is an improved method for generating electricity from a fuel cell having at least one electrode formed from a nano-carbon material. To increase the efficiency of the fuel cell, the electrode or catalyst containing nano-carbon material may be irradiated with blue color diode light, or an electric current may be directed to the nano-carbon material." George Suzuki, President of PFCE, stated: "While this is a milestone for Pacific Fuel Cell Corp., it is important to realize that our research team has been working to advance the technology represented by this patent for the last 2 years, and we believe that significant additional progress has been achieved." Pacific Fuel Cell Corp. owns the worldwide rights (excluding Japan) to this patented PEM (Proton Exchange Membrane) fuel cell technology. Using its extensive international relationships, the Company plans to create joint ventures to rapidly commercialize its innovative technology. Certain matters discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and, as such, may involve known and unknown risks and uncertainties and other factors that may cause the actual results to be materially different from the results implied herein. Readers are cautioned not to place undue reliance on the forward-looking statements made in this Press Release. KEYWORD: CALIFORNIA INDUSTRY KEYWORD: ENERGY SOURCE: Pacific Fuel Cell Corp. CONTACT INFORMATION: Pacific Fuel Cell Corp. Steve Godwin (Senior Advisor), 714-564-1693 * end of story *